Title | Author(s) | Issue date | ???itemlist.??? |
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study | Briasoulis, E.; Kalofonos, H.; Bafaloukos, D.; Samantas, E.; Fountzilas, G.; Xiros, N.; Skarlos, D.; Christodoulou, C.; Kosmidis, P.; Pavlidis, N. | 24-Nov-2015 | - |
Challenges in developing robust genetic markers and targets to predict and prevent distant and peritoneal recurrence in gastric cancer | Ziogas, D.; Roukos, D. H. | 24-Nov-2015 | - |
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective? | Pentheroudakis, G.; Briasoulis, E.; Karavassilis, V.; Fountzilas, G.; Xeros, N.; Samelis, G.; Samantas, E.; Pavlidis, N. | 24-Nov-2015 | - |
The clinical significance of soluble E-cadherin in nonsmall cell lung cancer | Charalabopoulos, K.; Gogali, A.; Dalavaga, Y.; Daskalopoulos, G.; Vassiliou, M.; Bablekos, G.; Karakosta, A.; Constantopoulos, S. | 24-Nov-2015 | - |
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas | Fine, H. A.; Figg, W. D.; Jaeckle, K.; Wen, P. Y.; Kyritsis, A. P.; Loeffler, J. S.; Levin, V. A.; Black, P. M.; Kaplan, R.; Pluda, J. M.; Yung, W. K. | 24-Nov-2015 | - |
Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients | Passadakis, P.; Ersoy, F.; Tam, P.; Memmos, D.; Siamopoulos, K.; Ozener, C.; Akcicek, F.; Camsari, T.; Ates, K.; Ataman, R.; Vlachojannis, J.; Dombros, N.; Utas, C.; Akpolat, T.; Bozfakioglu, S.; Wu, G. G.; Karayaylali, I.; Arinsoy, T.; Stathakis, C.; Yavuz, M.; Tsakiris, D.; Dimitriades, A.; Yilmaz, M. E.; Gultekin, M.; Karayalcin, B.; Challa, A.; Polat, N.; Oreopoulos, D. G. | 24-Nov-2015 | - |
Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers | Gogali, A.; Charalabopoulos, K.; Zampira, I.; Konstantinidis, A. K.; Tachmazoglou, F.; Daskalopoulos, G.; Constantopoulos, S. H.; Dalavanga, Y. | 24-Nov-2015 | - |